Literature DB >> 25109681

Tolerogenic dendritic cells and their applications in transplantation.

Haibin Li, Bingyi Shi.   

Abstract

In transplantation immunology, the ultimate goal is always to successfully and specifically induce immune tolerance of allografts. Tolerogenic dendritic cells (tol-DCs) with immunoregulatory functions have attracted much attention as they play important roles in inducing and maintaining immune tolerance. Here, we focused on tol-DCs that have the potential to promote immune tolerance after solid-organ transplantation. We focus on their development and interactions with other regulatory cells, and we also explore various tol-DC engineering protocols. Harnessing tol-DCs represents a promising cellular therapy for promoting long-term graft functional survival in transplant recipients that will most likely be achieved in the future.

Mesh:

Year:  2014        PMID: 25109681      PMCID: PMC4654373          DOI: 10.1038/cmi.2014.52

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  107 in total

1.  Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L.

Authors:  Li Qian; Cheng Qian; Yongjian Chen; Yi Bai; Yan Bao; Liwei Lu; Xuetao Cao
Journal:  Blood       Date:  2012-06-12       Impact factor: 22.113

Review 2.  Dendritic cells: understanding immunogenicity.

Authors:  Ralph M Steinman
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

3.  High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance.

Authors:  Daisuke Tokita; George V Mazariegos; Alan F Zahorchak; Nydia Chien; Masanori Abe; Giorgio Raimondi; Angus W Thomson
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

4.  Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.

Authors:  Maria T Pallotta; Ciriana Orabona; Claudia Volpi; Carmine Vacca; Maria L Belladonna; Roberta Bianchi; Giuseppe Servillo; Cinzia Brunacci; Mario Calvitti; Silvio Bicciato; Emilia M C Mazza; Louis Boon; Fabio Grassi; Maria C Fioretti; Francesca Fallarino; Paolo Puccetti; Ursula Grohmann
Journal:  Nat Immunol       Date:  2011-07-31       Impact factor: 25.606

5.  The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.

Authors:  Jun Yang; Leonardo V Riella; Susanne Chock; Tao Liu; Xiaozhi Zhao; Xueli Yuan; Alison M Paterson; Toshihiko Watanabe; Vijay Vanguri; Hideo Yagita; Miyuki Azuma; Bruce R Blazar; Gordon J Freeman; Scott J Rodig; Arlene H Sharpe; Anil Chandraker; Mohamed H Sayegh
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

Review 6.  Harnessing human dendritic cell subsets for medicine.

Authors:  Hideki Ueno; Nathalie Schmitt; Eynav Klechevsky; Alexander Pedroza-Gonzalez; Toshimichi Matsui; Gerard Zurawski; SangKon Oh; Joseph Fay; Virginia Pascual; Jacques Banchereau; Karolina Palucka
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

7.  Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient.

Authors:  E Sun; Y Gao; J Chen; A I Roberts; X Wang; Z Chen; Y Shi
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

Review 8.  Designing vaccines based on biology of human dendritic cell subsets.

Authors:  Karolina Palucka; Jacques Banchereau; Ira Mellman
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

9.  In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates.

Authors:  Kyeong Cheon Jung; Chung-Gyu Park; Yoon Kyung Jeon; Hyo Jin Park; Young Larn Ban; Hye Sook Min; Eun Ji Kim; Ju Hyun Kim; Byung Hyun Kang; Seung Pyo Park; Youngmee Bae; Il-Hee Yoon; Yong-Hee Kim; Jae-Il Lee; Jung-Sik Kim; Jun-Seop Shin; Jaeseok Yang; Sung Joo Kim; Emily Rostlund; William A Muller; Seong Hoe Park
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

10.  Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state.

Authors:  Matthew M Meredith; Kang Liu; Alice O Kamphorst; Juliana Idoyaga; Arito Yamane; Pierre Guermonprez; Suzannah Rihn; Kai-Hui Yao; Israel T Silva; Thiago Y Oliveira; Dimitris Skokos; Rafael Casellas; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-07-30       Impact factor: 14.307

View more
  43 in total

1.  Murine Sertoli cells promote the development of tolerogenic dendritic cells: a pivotal role of galectin-1.

Authors:  Jianxin Gao; Xujie Wang; Yunchuan Wang; Fu Han; Weixia Cai; Bin Zhao; Yan Li; Shichao Han; Xue Wu; Dahai Hu
Journal:  Immunology       Date:  2016-05-04       Impact factor: 7.397

2.  1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells.

Authors:  Zhongxiang Xie; Jingtao Chen; Chao Zheng; Jing Wu; Yun Cheng; Shan Zhu; Chenhong Lin; Qingqing Cao; Jie Zhu; Tao Jin
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 3.  Tolerogenic dendritic cells in organ transplantation.

Authors:  Jordi Ochando; Farideh Ordikhani; Stefan Jordan; Peter Boros; Angus W Thomson
Journal:  Transpl Int       Date:  2019-10-29       Impact factor: 3.782

Review 4.  The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Authors:  K Sanjana P Devi; Niroshana Anandasabapathy
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

5.  Generation of regulatory dendritic cells after treatment with paeoniflorin.

Authors:  Dan Chen; Yingxi Li; Xiaodong Wang; Keqiu Li; Yaqing Jing; Jinghua He; Zhaoyan Qiang; Jingzhi Tong; Ke Sun; Wen Ding; Yi Kang; Guang Li
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 6.  Photopheresis: Advances and Use in Systemic Sclerosis.

Authors:  Xiaolong Alan Zhou; Jaehyuk Choi
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

7.  Eosinophils promote inducible NOS-mediated lung allograft acceptance.

Authors:  Oscar Okwudiri Onyema; Yizhan Guo; Qing Wang; Mark H Stoler; Christine Lau; Kang Li; Christopher Daniel Nazaroff; Xingan Wang; Wenjun Li; Daniel Kreisel; Andrew E Gelman; James J Lee; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  JCI Insight       Date:  2017-12-21

8.  Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART.

Authors:  Roger J Bedimo; Hanna Mar; Ronald J Bosch; Henning Drechsler; Joshua C Cyktor; Barnard J C Macatangay; Christina Lalama; Charles Rinaldo; Ann Collier; Catherine Godfrey; Evelyn Hogg; Christopher Hensel; Joseph J Eron; Deborah K Mcmahon; John W Mellors; Pablo Tebas; Rajesh T Gandhi
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

9.  Dendritic Cells Treated with Exogenous Indoleamine 2,3-Dioxygenase Maintain an Immature Phenotype and Suppress Antigen-specific T cell Proliferation.

Authors:  Evelyn Bracho-Sanchez; Azadeh Hassanzadeh; Maigan A Brusko; Mark A Wallet; Benjamin G Keselowsky
Journal:  J Immunol Regen Med       Date:  2019-02-10

10.  Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells.

Authors:  Nady Braidy; Helene Rossez; Chai K Lim; Bat-Erdene Jugder; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2016-08-10       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.